143 related articles for article (PubMed ID: 2418860)
1. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
Mircheva J; Smith PJ; Bleehen NM
Br J Cancer; 1986 Jan; 53(1):99-103. PubMed ID: 2418860
[TBL] [Abstract][Full Text] [Related]
2. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
Smith PJ; Mircheva J; Bleehen NM
Br J Cancer; 1986 Jan; 53(1):105-14. PubMed ID: 2418859
[TBL] [Abstract][Full Text] [Related]
3. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells.
Smith PJ; Mircheva J; Bleehen NM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1363-6. PubMed ID: 2428790
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine.
Smith PJ; Mircheva JJ; Bleehen NM
Acta Physiol Pharmacol Bulg; 1987; 13(1):41-5. PubMed ID: 2441572
[TBL] [Abstract][Full Text] [Related]
5. The effect of pre- or post-treatment with a calmodulin inhibitor (trifluoperazine) on the response to cytotoxic agents of cells within small EMT6/Ca/VJAC spheroids.
Kwok TT; Twentyman PR
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1359-62. PubMed ID: 3759556
[TBL] [Abstract][Full Text] [Related]
6. Response of EMT6 multicellular tumour spheroids to hyperthermia and cytotoxic drugs.
Morgan JE; Bleehen NM
Br J Cancer; 1981 Mar; 43(3):384-91. PubMed ID: 6164381
[TBL] [Abstract][Full Text] [Related]
7. Chemical modulation of bleomycin induced toxicity.
Kennedy KA; Hait WN; Lazo JS
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1367-70. PubMed ID: 2428791
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.
Perez RP; Handel LM; Hamilton TC
Gynecol Oncol; 1992 Jul; 46(1):82-7. PubMed ID: 1634144
[TBL] [Abstract][Full Text] [Related]
9. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
[TBL] [Abstract][Full Text] [Related]
10. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
Zhang HQ; He NG; Xue SB
Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
[TBL] [Abstract][Full Text] [Related]
11. Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
Dogramatzis D; Nishikawa K; Newman RA
Anticancer Res; 1991; 11(3):1359-64. PubMed ID: 1716087
[TBL] [Abstract][Full Text] [Related]
12. The effect of bleomycin and pentamycin in combination on the survival of EMT6 mouse tumour cells in vitro and in vivo.
Twentyman PR
Br J Cancer; 1976 Apr; 33(4):459-64. PubMed ID: 57791
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
[TBL] [Abstract][Full Text] [Related]
14. Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
Ganapathi R; Schmidt H; Grabowski D; Melia M; Ratliff N
Br J Cancer; 1988 Sep; 58(3):335-40. PubMed ID: 3179186
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53.
Sullivan GF; Garcia-Welch A; White E; Lutzker S; Hait WN
J Exp Ther Oncol; 2002; 2(1):19-26. PubMed ID: 12415616
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells. Lack of correlation between cellular doxorubicin levels and expression of resistance.
Ganapathi R; Grabowski D
Biochem Pharmacol; 1988 Jan; 37(2):185-93. PubMed ID: 3342075
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.
Frankfurt OS; Sugarbaker EV; Robb JA; Villa L
Cancer Lett; 1995 Nov; 97(2):149-54. PubMed ID: 7497456
[TBL] [Abstract][Full Text] [Related]
18. The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non small cell lung carcinoma cells to DNA double-strand break induced cell death.
Polischouk AG; Holgersson A; Zong D; Stenerlöw B; Karlsson HL; Möller L; Viktorsson K; Lewensohn R
Mol Cancer Ther; 2007 Aug; 6(8):2303-9. PubMed ID: 17699725
[TBL] [Abstract][Full Text] [Related]
19. Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cells.
Ganapathi R; Grabowski D; Hoeltge G; Neelon R
Biochem Pharmacol; 1990 Oct; 40(7):1657-62. PubMed ID: 2222519
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
